Christopher Tretter

1.5k total citations · 1 hit paper
12 papers, 1.1k citations indexed

About

Christopher Tretter is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Christopher Tretter has authored 12 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 6 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Christopher Tretter's work include Bladder and Urothelial Cancer Treatments (4 papers), Immunotherapy and Immune Responses (3 papers) and Urinary and Genital Oncology Studies (3 papers). Christopher Tretter is often cited by papers focused on Bladder and Urothelial Cancer Treatments (4 papers), Immunotherapy and Immune Responses (3 papers) and Urinary and Genital Oncology Studies (3 papers). Christopher Tretter collaborates with scholars based in United States and United Kingdom. Christopher Tretter's co-authors include John W. Smith, Michael B. Atkins, Janice P. Dutcher, Walter J. Urba, Jeffrey A. Sosman, Geoffrey R. Weiss, Theodore F. Logan, Joseph I. Clark, Kim Margolin and Michael S. Gordon and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and The Prostate.

In The Last Decade

Christopher Tretter

11 papers receiving 1.1k citations

Hit Papers

Randomized Phase III Trial of High-Dose Interleukin-2 Ver... 2004 2026 2011 2018 2004 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2 and Interferon in Patients With Metastatic Renal Cell Carcinoma
    2004 598 citations David F. McDermott, Meredith M. Regan et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Tretter United States 8 668 471 429 381 361 12 1.1k
Ashley Marie Regazzi United States 14 369 0.6× 330 0.7× 592 1.4× 146 0.4× 803 2.2× 71 1.2k
Arash Rezazadeh Kalebasty United States 14 531 0.8× 364 0.8× 630 1.5× 164 0.4× 442 1.2× 69 1.2k
Hendrik-Tobias Arkenau United Kingdom 9 526 0.8× 339 0.7× 1.2k 2.7× 208 0.5× 760 2.1× 11 1.6k
Melissa Plets United States 19 523 0.8× 341 0.7× 450 1.0× 241 0.6× 534 1.5× 56 1.2k
Farhood Alamdari Sweden 13 431 0.6× 355 0.8× 174 0.4× 162 0.4× 232 0.6× 29 669
Michael D. Gillett United States 8 525 0.8× 263 0.6× 945 2.2× 155 0.4× 195 0.5× 10 1.3k
Mélanie Claps Italy 15 384 0.6× 220 0.5× 227 0.5× 291 0.8× 261 0.7× 57 692
Sohail Balasubramanian United States 14 433 0.6× 368 0.8× 471 1.1× 371 1.0× 322 0.9× 24 1.1k
Amin H. Nassar United States 17 396 0.6× 318 0.7× 454 1.1× 216 0.6× 250 0.7× 74 886
A. Kooistra Netherlands 12 576 0.9× 326 0.7× 403 0.9× 198 0.5× 110 0.3× 19 928

Countries citing papers authored by Christopher Tretter

Since Specialization
Citations

This map shows the geographic impact of Christopher Tretter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Tretter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Tretter more than expected).

Fields of papers citing papers by Christopher Tretter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Tretter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Tretter. The network helps show where Christopher Tretter may publish in the future.

Co-authorship network of co-authors of Christopher Tretter

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Tretter. A scholar is included among the top collaborators of Christopher Tretter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Tretter. Christopher Tretter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Varkaris, Andreas, Krishna S. Gunturu, Tarun Kewalramani, & Christopher Tretter. (2016). Acute Myeloid Leukemia After Radium-223 Therapy: Case Report. Clinical Genitourinary Cancer. 15(4). e723–e726. 9 indexed citations
2.
Choueiri, Toni K., Susanna Jacobus, Joaquim Bellmunt, et al.. (2014). Neoadjuvant Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With Pegfilgrastim Support in Muscle-Invasive Urothelial Cancer: Pathologic, Radiologic, and Biomarker Correlates. Journal of Clinical Oncology. 32(18). 1889–1894. 184 indexed citations
3.
4.
Tretter, Christopher, et al.. (2011). Value of 18F-FDG in the assessment of patients with upper tract urothelial carcinoma. 52. 1917–1917.
5.
Vassilopoulou‐Sellin, Rena, Antonio Tito Fojo, William Oh, et al.. (2007). A phase II trial of gefitinib monotherapy in patients with unresectable adrenocortical carcinoma (ACC). Journal of Clinical Oncology. 25(18_suppl). 15527–15527. 42 indexed citations
6.
Schwaab, Thomas, Christopher Tretter, Jennifer Gibson, et al.. (2006). Tumor‐related immunity in prostate cancer patients treated with human recombinant granulocyte monocyte‐colony stimulating factor (GM‐CSF). The Prostate. 66(6). 667–674. 16 indexed citations
7.
Crocenzi, Todd S., Christopher Tretter, Thomas Schwaab, et al.. (2005). Impaired cytolytic activity in peripheral blood T cells from renal cell carcinoma patients. Clinical Immunology. 117(1). 6–11. 7 indexed citations
8.
Ernstoff, Marc S., et al.. (2005). Primary adrenocortical tumors: EGFR, c-Kit and Her-2/neu receptor staining patterns. Journal of Clinical Oncology. 23(16_suppl). 4770–4770. 1 indexed citations
9.
McDermott, David F., Meredith M. Regan, Joseph I. Clark, et al.. (2004). Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2 and Interferon in Patients With Metastatic Renal Cell Carcinoma. Journal of Clinical Oncology. 23(1). 133–141. 598 indexed citations breakdown →
10.
Schwaab, Thomas, Christopher Tretter, Jennifer Gibson, et al.. (2004). Immunological Effects of Granulocyte-Macrophage Colony-Stimulating Factor and Autologous Tumor Vaccine in Patients With Renal Cell Carcinoma. The Journal of Urology. 171(3). 1036–1042. 16 indexed citations
11.
Tretter, Christopher, Lionel D. Lewis, James L. Fisher, Mary Waugh, & Marc S. Ernstoff. (2003). Taxanes Synergize with the Bispecific Antibody MDXH447 to Enhance Antibody-Dependent Cell-Mediated Cytotoxicity. Journal of Chemotherapy. 15(5). 472–479. 4 indexed citations
12.
Clark, Joseph I., Michael B. Atkins, Walter J. Urba, et al.. (2003). Adjuvant High-Dose Bolus Interleukin-2 for Patients With High-Risk Renal Cell Carcinoma: A Cytokine Working Group Randomized Trial. Journal of Clinical Oncology. 21(16). 3133–3140. 209 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ashley Marie Regazzi Breakdown of academic impact, for papers by Arash Rezazadeh Kalebasty Breakdown of academic impact, for papers by Hendrik-Tobias Arkenau Breakdown of academic impact, for papers by Melissa Plets Breakdown of academic impact, for papers by Farhood Alamdari Breakdown of academic impact, for papers by Michael D. Gillett Breakdown of academic impact, for papers by Mélanie Claps Breakdown of academic impact, for papers by Sohail Balasubramanian Breakdown of academic impact, for papers by Amin H. Nassar Breakdown of academic impact, for papers by A. Kooistra
Rankless by CCL
2026